Hansa Biopharma to Participate in Two Upcoming Investor Conferences

LUND, Sweden, Feb. 25, 2020 /PRNewswire/ --  Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced that the Company's management team will participate in the following upcoming investor conferences: 

• Cowen and Company's 40th Annual Health Care Conference in Boston on Monday, March 2, 2020, with a presentation at 4:10 PM EST/ 22:10 CET on the same day.
• The Carnegie Nordic Healthcare Seminar in Stockholm on Wednesday, March 4, 2020, with a presentation at 8:00 AM CET

A live webcast of the Cowen presentation will be available on the Events & Webcast page of the Company's website, www.hansabiopharma.com . A replay of the presentation will be available approximately two hours after the event and will be available for two weeks following the presentation.

Calendar 2020

CONTACT:

For further information, please contact:
Klaus Sindahl, Head of Investor Relations
Hansa Biopharma
Mobile: +46 (0) 709-298 269
E-mail: klaus.sindahl@hansabiopharma.com

Rolf Gulliksen
Head of Corporate Communications
Hansa Biopharma
Mobile: +46 (0) 733-328 634
E-mail: rolf.gulliksen@hansabiopharma.com

This information was brought to you by Cision http://news.cision.com 

https://news.cision.com/hansa-biopharma-ab/r/hansa-biopharma-to-participate-in-two-upcoming-investor-conferences,c3043193

The following files are available for download:

View original content:http://www.prnewswire.com/news-releases/hansa-biopharma-to-participate-in-two-upcoming-investor-conferences-301010445.html

SOURCE Hansa Biopharma AB